ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,058.17
0.79%
US Tech 100
17,096.00
1.39%
다우존스 지수
38,169.04
0.70%
Bitcoin
59,055.74
1.40%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Castle Biosciences Inc (CSTL)

  7. Castle Biosciences Inc (CSTL) 뉴스

CSTL Castle Biosciences Inc

22.895
0.875 (3.97%)
최종 업데이트: 04:21:45
15분 지연
기업명 주식 심볼 시장 주식 타입
Castle Biosciences Inc CSTL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.875 3.97% 22.895 04:21:45
개장가 저가 고가 종가 전일 종가
22.14 21.7379 23.19 22.02
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202405:30BWCastle Biosciences Kicks off Skin Cancer Awareness Month..
11/04/202420:00BWCastle Biosciences to Release First Quarter 2024 Financial..
11/04/202406:00BWCastle Biosciences Celebrates Esophageal Cancer Awareness..
10/04/202420:00BWCastle Biosciences’ Chief Financial Officer Frank Stokes..
05/04/202405:30BWPresentations at EADO Highlight Potential Impact of Castle..
02/04/202420:00BWCastle Biosciences to Present at the 23rd Annual Needham..
28/03/202406:00BWCastle Biosciences Announces Updates to its Board of..
25/03/202420:00BWCastle Biosciences Earns a Top Workplaces USA Award for the..
23/03/202405:30BWLong-term Outcomes Data Shared at SSO 2024 Show That..
19/03/202420:00BWLeading Squamous Cell Carcinoma Practitioners Publish..
16/03/202405:30BWNew Study Shows that the Drug-Drug Interactions and..
12/03/202420:00BWCastle Biosciences to Present at the KeyBanc Capital Markets..
09/03/202406:30BWCastle Biosciences to Present New Data Highlighting the..
07/03/202421:00BWIn Novel Cohort, New Data Confirms DecisionDx®-SCC Provides..
07/03/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202407:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/02/202406:05BWCastle Biosciences Reports Fourth Quarter and Full-Year 2023..
26/02/202421:00BWStudy Finds DecisionDx®-Melanoma Significantly Improves the..
07/02/202421:00BWCastle Biosciences to Release Fourth Quarter and Full-Year..
18/01/202421:00BWNew Study Highlights Significant Potential Medicare Savings..
14/01/202418:30BWCastle Biosciences Presents Data Supporting the Utility of..
09/01/202421:00BWCastle Biosciences’ Chief Operating Officer Kristen..
08/01/202421:04EDGAR2Form 8-K - Current report
08/01/202410:00BWCastle Biosciences Announces Preliminary Fourth Quarter and..
05/01/202407:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202321:00BWCastle Biosciences Reports Inducement Grants Under Nasdaq..
13/12/202309:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:50EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/12/202321:00BWStudy Finds Nurse Practitioners and Physician Assistants..
14/11/202321:00BWCastle Biosciences Announces Multiple Data Presentations at..
13/11/202321:00BWCastle Biosciences Ranked Among the Top Workplaces in..
10/11/202307:25EDGAR2Form 8-K - Current report
09/11/202306:30BWReal-World Evidence Confirms IDgenetix®-Guided Medication..
09/11/202303:00BWCastle Biosciences to Present at Upcoming Investor..
03/11/202320:00BWCastle Announces Early Exploratory Study Data for Potential..
03/11/202305:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202305:06BWEarly Discovery Data Shows Ability of Castle Biosciences’..
03/11/202305:05BWCastle Biosciences Reports Third Quarter 2023 Results
24/10/202320:00BWCastle Biosciences to Present New Data on its TissueCypher®..
19/10/202320:00BWCastle Biosciences to Release Third Quarter 2023 Financial..
19/10/202305:30BWNew Data Highlights Clinical Utility and Performance of..
05/10/202320:00BWDecisionDx®-Melanoma Outperforms Memorial Sloan Kettering..
03/10/202320:00BWCastle Biosciences Presents New Data at ASTRO 2023..
02/10/202320:00BWCastle Biosciences Shares New Data Demonstrating Ability of..
25/09/202320:00BWCastle Biosciences, Leading Skin Cancer Expert, Darrell..

최근 히스토리

NASDAQ
CSTL
Castle Biosciences
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유